27–30 Sept 2022
Hotel NH Nice
Europe/Paris timezone

The Editorial Board

Click on the underlined names if you want to learn more about the board members!

Standing members 

Dr Ian Cree   (Editorial Board Chair)
International Agency for Research on Cancer
Lyon, France
creei@iarc.fr

Dr Erika Denton (remote participation)
Norfolk & Norwich University Hospital
Norwich, United Kingdom
erika.denton@nnuh.nhs.uk

Dr Michael Eden
Cambridge University Hospitals NHS Trust
Cambridge, United Kingdom
Michael.Eden@phe.gov.uk

Dr Andrew Field (remote participation)
St Vincent’s Hospital Sydney
Sydney, New South Wales, Australia
Andrew.Field@svha.org.au

Dr Anthony Gill
Royal North Shore Hospital
St Leonards, Australia
Anthony.Gill@health.nsw.gov.au

Dr Jennelle Hodge
Indiana University School of Medicine
Indianapolis, USA
jhodge1@iu.edu

Dr Joseph Khoury
University of Nebraska Medical Center
Omaha, USA
jkhoury@unmc.edu

Dr Alexander Lazar
UT-MD Anderson Cancer Center
Houston, USA
alazar@mdanderson.org

Dr Katia Leite
University of Sao Paulo Medical School
Sao Paulo, Brazil
katiaramos@usp.br

Dr Zhiyong Liang (remote participation)
Peking Union Medical College Hospital
Beijing, China
liangzhiyong1220@yahoo.com

Dr Daichi Maeda
Kanazawa University
Kanazawa, Japan
daichimaeda@gmail.com

Dr Holger Moch (remote participation)
University Hospital Zurich
Zurich, Switzerland
holger.moch@usz.ch

Dr Bharat Rekhi 
Tata Memorial Centre, HBNI University
Mumbai, Maharashtra, India
rekhi.bharat@gmail.com

Dr Brian Rous (remote participation)
National Cancer Registry and Analysis Service
Cambridge, United Kingdom
brian.rous@nhs.net

Dr Shahin Sayed
Aga Khan University
Nairobi, Kenya
shaheen.sayed@aku.edu

Dr Puay Hoon Tan
Singapore General Hospital
Singapore
tan.puay.hoon@singhealth.com.sg

Dr Lester D.R. Thompson
Southern California Permanente Medical Group
Woodland Hills, USA
Lester.D.Thompson@kp.org

Dr Kay Washington
Vanderbilt University Medical Center
Nashville, USA
kay.washington@vanderbilt.edu

 

Expert members: Genetic tumour syndromes

Dr Yassmine Akkari
The Steve and Cindy Rasmussen Institute for Genomic Medicine
Nationwide Children’s Hospital
Columbus, USA
Yassmine.akkari@nationwidechildrens.org  

Dr Mark J. Arends
University of Edinburgh
Edinburgh, United Kingdom
M.Arends@ed.ac.uk

Dr Elspeth Bruford (remote participation)
University of Cambridge
Cambridge, United Kingdom
elspeth@ebi.ac.uk

Dr Raymond Dalgleish
University of Leicester
Leicester, United Kingdom
raymond.dalgleish@le.ac.uk

Dr William D. Foulkes (remote participation)
McGill University Health Centre
Montreal, Canada

william.foulkes@mcgill.ca

Dr Ian M. Frayling
St Mark's Hospital
Harrow, United Kingdom
FraylingIM@cardiff.ac.uk

Dr Ada Hamosh
Johns Hopkins University
Baltimore, USA
ahamosh@jhmi.edu

Dr Stefan Pfister
German Cancer Research Center (DKFZ)
Heidelberg, Germany
s.pfister@kitz-heidelberg.de

Dr Sharon Plon
Baylor College of Medicine
Houston, USA
splon@bcm.edu

Dr Mark J. Rubin
University of Bern
Bern, Switzerland
mark.rubin@dbmr.unibe.ch

Dr Aldo Scarpa
ARC-Net Research Centre
Verona, Italy
aldo.scarpa@univr.it

Dr Michael Walsh (remote participation)
Memorial Sloan Kettering Cancer Center
New York, USA
walshm2@mskcc.org